Bayer stock gains 4.43 percent against Xetra close: EUR 45.93
Published on 10/24/2026 at 10:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSWeekend price and dates
- Bayer’s October 8 investor update reported U.S. FDA acceptance of a finerenone filing.
- Bayer stock trades in weekend trading at Lang & Schwarz at EUR 45.93 at 10:36 a.m. CEST on October 24, 2026, 4.43 percent above the Xetra close of October 23, 2026.
- The next Xetra session is scheduled for October 26, 2026.
Bayer stock was 4.43 percent above the Xetra close of October 23, 2026, in weekend trading. At 10:36 a.m. CEST on October 24, 2026, the stock traded at EUR 45.93 at Lang & Schwarz, compared with the Xetra close of EUR 43.98.
Market context: Market report DAX.
The week in figures
The current weekend-trading price is EUR 45.93. Measured against the Xetra close of EUR 43.98 on October 23, 2026, that represents a gain of 4.43 percent. Xetra is closed during the weekend trading phase.
The further course of weekend trading at Lang & Schwarz until 1:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Bayer stock.
Recent issuer announcement
Bayer’s investor-news page dated October 8, 2026, reported that the U.S. Food and Drug Administration accepted the company’s supplemental New Drug Application for finerenone in chronic kidney disease without diabetes. The filing was based on positive Phase III FIND-CKD study results, according to the company.
Next Xetra session
The next Xetra session is scheduled for October 26, 2026. The weekend quote and the dated company announcement are separate pieces of information; the company source does not attribute the market move to the filing.
